We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+7.48%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$111B
AUM Growth
+$4.45B
Cap. Flow
-$1.78B
Cap. Flow %
-1.61%
Top 10 Hldgs %
29%
Holding
4,480
New
63
Increased
1,265
Reduced
2,421
Closed
236

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$46M
2
PLTR icon
Palantir
PLTR
+$40.3M
3
SW
Smurfit Westrock
SW
+$39.2M
4
DELL icon
Dell
DELL
+$29.2M
5
AVTR icon
Avantor
AVTR
+$27.1M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$97.8M
2
LLY icon
Eli Lilly
LLY
+$58.2M
3
NVDA icon
NVIDIA
NVDA
+$48.6M
4
XOM icon
ExxonMobil
XOM
+$31.3M
5
BAC icon
Bank of America
BAC
+$30.5M

Sector Composition

Rank Sector Weight
1 Technology 30.19%
2 Financials 12.91%
3 Healthcare 11.38%
4 Consumer Discretionary 10.81%
5 Industrials 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPTN
3826
DELISTED
OptiNose
OPTN
-604
Closed -$9.41K
ORGN
3827
DELISTED
Origin Materials
ORGN
-1,968
Closed -$53.2K
ORMP icon
3828
Oramed Pharmaceuticals
ORMP
$179M
-1,830
Closed -$4.7K
PASG icon
3829
Passage Bio
PASG
$14.1M
-39
Closed -$621
PAY icon
3830
Paymentus
PAY
$4.86B
-844
Closed -$16K
PDSB icon
3831
PDS Biotechnology
PDSB
$43.4M
-11,537
Closed -$33.8K
PHX
3832
DELISTED
PHX Minerals
PHX
-600
Closed -$1.96K
PIII icon
3833
P3 Health Partners
PIII
$38.5M
-279
Closed -$6.27K
PLX icon
3834
Protalix BioTherapeutics
PLX
$198M
-17,666
Closed -$20.7K
PMVP icon
3835
PMV Pharmaceuticals
PMVP
$63.5M
-23,035
Closed -$37.3K
PPBT
3836
Purple Biotech
PPBT
$2.33M
0
-$6
PRTS icon
3837
CarParts.com
PRTS
$54.7M
-2,722
Closed -$27.2K
PWOD
3838
DELISTED
Penns Woods Bancorp
PWOD
-453
Closed -$9.31K
PXLW icon
3839
Pixelworks
PXLW
$41.6M
-104
Closed -$1.23K
QNCX icon
3840
Quince Therapeutics
QNCX
$29.5M
-2
Closed -$295
RANI icon
3841
Rani Therapeutics
RANI
$89M
-312
Closed -$1.19K
RBOT
3842
DELISTED
Vicarious Surgical
RBOT
-700
Closed -$4.11K
RENT
3843
Rent the Runway
RENT
$124M
-1,138
Closed -$20K
RLMD icon
3844
Relmada Therapeutics
RLMD
$527M
-1,125
Closed -$3.38K
RLYB icon
3845
Rallybio
RLYB
$85.8M
-1,297
Closed -$13.9K
RRGB icon
3846
Red Robin
RRGB
$152M
-7,883
Closed -$59.7K
SEER icon
3847
Seer Inc
SEER
$120M
-28,885
Closed -$48.5K
SENS icon
3848
Senseonics Holdings Inc
SENS
$366M
-714
Closed -$5.7K
SGMO
3849
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
-59,653
Closed -$21.4K
SGMT icon
3850
Sagimet Biosciences
SGMT
$559M
-6,111
Closed -$20.9K

Similar funds

RhumbLine Advisers's Q3 2024 Portfolio in Review

As of Q3 2024, RhumbLine Advisers held 4,480 positions worth $111B, up 4.2% from $106B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

RhumbLine Advisers's Q3 2024 filing shows 63 new, 1,265 increased, 2,421 reduced and 236 closed positions. Its largest new stake was Smurfit Westrock: 860,959 shares worth $42.5M. The largest sale was Microsoft, an estimated $97.8M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2024 buy was Smurfit Westrock: 860,959 shares worth $42.5M.
  • RhumbLine Advisers added most to Apple in Q3 2024, an estimated $46M increase.
  • RhumbLine Advisers's biggest Q3 2024 reduction was Microsoft, cutting an estimated $97.8M.
  • RhumbLine Advisers fully exited Expand Energy Corp in Q3 2024, selling an estimated $27.4M.
  • RhumbLine Advisers's ten largest holdings make up 29% of its $111B portfolio in Q3 2024.
  • RhumbLine Advisers opened 63 new positions and closed 236 in Q3 2024.
  • RhumbLine Advisers's portfolio value rose 4.2% quarter-over-quarter to $111B.

Based on RhumbLine Advisers's 13F filing for Q3 2024, filed 12 Nov 2024.